RESEARCH TRIANGLE PARK, NC (October 1, 2024) – Dignify Therapeutics (Dignify), a specialty pharma company focused on resorting bowel and bladder function in patients with neurological diseases will be a presenting company at the BIO Investor Forum in San Francisco at the Fairmount Hotel at 11:15am on October 16, 2024. Dignify is developing two products…
RESEARCH TRIANGLE PARK, NC (October 10, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Howard Palefsky and Dr. Neil Kurtz have joined Dignify’s Board of Directors. Mr. Palefsky has a broad range of experience as a Board Member and Advisor in the healthcare and biomedical industries,…
RESEARCH TRIANGLE PARK, NC (September 19, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two significant research grants from the NIH. These grants add to the previous $20 million in research funding the company has received to advance multiple therapeutics for bladder and bowel disorders. Grants…
RESEARCH TRIANGLE PARK, NC (August 5, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Dr. Rabchevsky has joined Dignify’s Scientific Advisory Board (SAB). Dr. Rabchevsky is currently Professor of Physiology and inaugural faculty member of the Spinal Cord & Brain Injury Research Center at the University…
RESEARCH TRIANGLE PARK, NC (March 18, 2024) – Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly and neurologically impaired individuals, today announced that Anthony DiTonno has been named as Chief Executive Officer. This appointment expands Mr. DiTonno’s duties as he will continue in his…